1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Robotic Systems Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Robotic Systems Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Surgical Robotic Systems for Minimally Invasive Surgeries
5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
5.4. COVID-19 Pandemic Impact on Industry
6. Medical Robotic Systems Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2023–2031
6.3.1. Surgical Robots
6.3.1.1. Orthopedic Robotic Systems
6.3.1.2. Neurosurgery Robotic Systems
6.3.1.3. General Laparoscopy Robotic Systems
6.3.1.4. Steerable Robotic Catheters
6.3.2. Non-invasive Radiosurgery Robotic Systems
6.3.3. Emergency Response Robotic Systems
6.3.4. Prosthetics/Exoskeletons
6.3.5. Assistive and Rehabilitation Systems
6.3.6. Non-medical Robotics in Hospitals
6.3.6.1. Telemedicine Robots
6.3.6.2. Cart Transportation Robots
6.3.6.3. Robotic Hospital Pharmacies
6.4. Market Attractiveness, by Product
7. Global Medical Robotic Systems Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region, 2023–2031
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness, by Region
8. North America Medical Robotic Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Product, 2023–2031
8.2.1. Surgical Robots
8.2.1.1. Orthopedic Robotic Systems
8.2.1.2. Neurosurgery Robotic Systems
8.2.1.3. General Laparoscopy Robotic Systems
8.2.1.4. Steerable Robotic Catheters
8.2.2. Non-invasive Radiosurgery Robotic Systems
8.2.3. Emergency Response Robotic Systems
8.2.4. Prosthetics/Exoskeletons
8.2.5. Assistive and Rehabilitation Systems
8.2.6. Non-medical Robotics in Hospitals
8.2.6.1. Telemedicine Robots
8.2.6.2. Cart Transportation Robots
8.2.6.3. Robotic Hospital Pharmacies
8.2.7. Market Attractiveness, by Product
8.3. Market Value Forecast, by Country, 2023–2031
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Product
8.4.2. By Country
9. Europe Medical Robotic Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2023–2031
9.2.1. Surgical Robots
9.2.1.1. Orthopedic Robotic Systems
9.2.1.2. Neurosurgery Robotic Systems
9.2.1.3. General Laparoscopy Robotic Systems
9.2.1.4. Steerable Robotic Catheters
9.2.2. Non-invasive Radiosurgery Robotic Systems
9.2.3. Emergency Response Robotic Systems
9.2.4. Prosthetics/Exoskeletons
9.2.5. Assistive and Rehabilitation Systems
9.2.6. Non-medical Robotics in Hospitals
9.2.6.1. Telemedicine Robots
9.2.6.2. Cart Transportation Robots
9.2.6.3. Robotic Hospital Pharmacies
9.2.7. Market Attractiveness, by Product
9.3. Market Value Forecast, by Country/Sub-region, 2023–2031
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Product
9.4.2. By Country/Sub-region
10. Asia Pacific Medical Robotic Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2023–2031
10.2.1. Surgical Robots
10.2.1.1. Orthopedic Robotic Systems
10.2.1.2. Neurosurgery Robotic Systems
10.2.1.3. General Laparoscopy Robotic Systems
10.2.1.4. Steerable Robotic Catheters
10.2.2. Non-invasive Radiosurgery Robotic Systems
10.2.3. Emergency Response Robotic Systems
10.2.4. Prosthetics/Exoskeletons
10.2.5. Assistive and Rehabilitation Systems
10.2.6. Non-medical Robotics in Hospitals
10.2.6.1. Telemedicine Robots
10.2.6.2. Cart Transportation Robots
10.2.6.3. Robotic Hospital Pharmacies
10.2.7. Market Attractiveness, by Product
10.3. Market Value Forecast, by Country/Sub-region, 2023–2031
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Product
10.4.2. By Country/Sub-region
11. Latin America Medical Robotic Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2023–2031
11.2.1. Surgical Robots
11.2.1.1. Orthopedic Robotic Systems
11.2.1.2. Neurosurgery Robotic Systems
11.2.1.3. General Laparoscopy Robotic Systems
11.2.1.4. Steerable Robotic Catheters
11.2.2. Non-invasive Radiosurgery Robotic Systems
11.2.3. Emergency Response Robotic Systems
11.2.4. Prosthetics/Exoskeletons
11.2.5. Assistive and Rehabilitation Systems
11.2.6. Non-medical Robotics in Hospitals
11.2.6.1. Telemedicine Robots
11.2.6.2. Cart Transportation Robots
11.2.6.3. Robotic Hospital Pharmacies
11.2.7. Market Attractiveness, by Product
11.3. Market Value Forecast, by Country/Sub-region, 2023–2031
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Product
11.4.2. By Country/Sub-region
12. Middle East & Africa Medical Robotic Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2023–2031
12.2.1. Surgical Robots
12.2.1.1. Orthopedic Robotic Systems
12.2.1.2. Neurosurgery Robotic Systems
12.2.1.3. General Laparoscopy Robotic Systems
12.2.1.4. Steerable Robotic Catheters
12.2.2. Non-invasive Radiosurgery Robotic Systems
12.2.3. Emergency Response Robotic Systems
12.2.4. Prosthetics/Exoskeletons
12.2.5. Assistive and Rehabilitation Systems
12.2.6. Non-medical Robotics in Hospitals
12.2.6.1. Telemedicine Robots
12.2.6.2. Cart Transportation Robots
12.2.6.3. Robotic Hospital Pharmacies
12.2.7. Market Attractiveness, by Product
12.3. Market Value Forecast, by Country/Sub-region, 2023–2031
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Product
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of Companies)
13.2. Market Share Analysis, by Company (2022)
13.3. Company Profiles
13.3.1. Intuitive Surgical Inc.
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Product Portfolio
13.3.1.3. Financial Overview
13.3.1.4. SWOT Analysis
13.3.1.5. Strategic Overview
13.3.2. Accuray Incorporated
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Product Portfolio
13.3.2.3. Financial Overview
13.3.2.4. SWOT Analysis
13.3.2.5. Strategic Overview
13.3.3. Hansen Medical Inc.
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Product Portfolio
13.3.3.3. Financial Overview
13.3.3.4. SWOT Analysis
13.3.3.5. Strategic Overview
13.3.4. Aethon
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Product Portfolio
13.3.4.3. Financial Overview
13.3.4.4. SWOT Analysis
13.3.4.5. Strategic Overview
13.3.5. Asensus Surgical
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Product Portfolio
13.3.5.3. Financial Overview
13.3.5.4. SWOT Analysis
13.3.5.5. Strategic Overview
13.3.6. Stereotaxis Inc.
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Product Portfolio
13.3.6.3. Financial Overview
13.3.6.4. SWOT Analysis
13.3.6.5. Strategic Overview
13.3.7. ReWalk Robotics
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Product Portfolio
13.3.7.3. Financial Overview
13.3.7.4. SWOT Analysis
13.3.7.5. Strategic Overview
13.3.8. Titan Medical Inc.
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Product Portfolio
13.3.8.3. Financial Overview
13.3.8.4. SWOT Analysis
13.3.8.5. Strategic Overview
13.3.9. Stryker
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Product Portfolio
13.3.9.3. Financial Overview
13.3.9.4. SWOT Analysis
13.3.9.5. Strategic Overview
13.3.10. Medtech SA
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Product Portfolio
13.3.10.3. Financial Overview
13.3.10.4. SWOT Analysis
13.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
